Beam Therapeutics Inc (BEAM): Balans kapitallashuviga qarzlar

Beam Therapeutics Corp (BEAM) tovar belgisi

Beam Therapeutics Inc. (BEAM) biznesi YaIM ta'siriga bo'ysunmaydi, chunki tadqiqot va ishlanmalar (R&D) loyihalarining muvaffaqiyati fanga bog'liq va joriy ko'rsatkich 0.24 hisoblanadi. Ushbu narxlar grafigi nuqtali mutatsiyalarni bartaraf etish uchun "genetik o'chirg'ich" yaratayotgan kompaniyaning faoliyatini aks ettiradi. Strategiya zanjir uzilishlarisiz aniq DNK tuzatishiga asoslanib, irsiy jigar va qon patologiyalarini davolash imkonini beradi.

Beam Tx (BEAM) - Balans qiymatiga qarzlar 04.07.2022dan 28.10.2026gacha

Beam Therapeutics Inc (BEAM) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Beam Therapeutics Inc.|BEAM - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Beam Tx|BEAM - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Beam Therapeutics|BEAM - Kompaniyaning xususiy kapitali|Bozor kapitallashuvining balans qiymatiga nisbati beamtx.com|BEAM - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Beam Therapeutics Inc.|BEAM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Beam Therapeutics Corp|BEAM - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati Beam Tx|BEAM - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Beam Therapeutics
Kompaniyaning barcha koʻrsatkichlari tahlili:BEAM Beam Therapeutics Inc.
Beam Tx tomonidan chiqariladigan mahsulotlar

Beam Therapeutics Inc. (BEAM) sog'liqni saqlash gigantlaridan tushadigan litsenziyalash daromadlari orqali barqarorlikni saqlaydi, bu esa Base Editing texnologiyalarini ishlab chiqish jarayonida tashqi qarzlarga bo'lgan bog'liqlikni minimallashtiradi. Ushbu ko'rsatkich umumiy majburiyatlarning sof aktivlar qiymatiga nisbatini hisoblaydi, bu esa defolt xatarlarini aniqlash uchun kompaniyaning moliyaviy leveraj trayektoriyasi orqali qarz yuklamasi va kapital o'rtasidagi muvozanatni baholash imkonini beradi.

Beam Therapeutics Inc. raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|Balans kapitallashuviga qarzlar qiagen.com QGEN|IONS - Balans kapitallashuviga qarzlar|RGEN - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar RNA|CRISPR (CRSP) - Balans qiymatiga qarzlar|WGS (GeneDx Holdings Corp.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar RARE|Qarzning balans kapitallashuviga nisbati SRPT (Sarepta)|Qarzning balans qiymatiga nisbati Twist Bioscience Inc TWST|Qarzning balans qiymatiga nisbati 10x Genomics Corp|NTLA - Qarzning sof aktivlarga nisbati|Qarzning balans qiymatiga nisbati Stoke Therapeutics STOK|BLFS - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Wave Life Sciences Ltd. WVE|Maze Therapeutics, Inc. (MAZE) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SION (Sionna Pharma)|Balans qiymatiga qarzlar PRME|Taysha Gene Therapies (TSHA) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati uniqure.com (QURE)|Balans kapitallashuviga qarzlar MGTX (MeiraGTx)|REGENXBIO Inc - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Solid Bio|OCGN - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar PACB|Balans qiymatiga qarzlar benitec.com|DSGN (Design Therapeutics, Inc.) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Rocket Pharma (RCKT)|Qarzning balans qiymatiga nisbati 4D Molecular Therapeutics Inc|Qarzning balans kapitaliga nisbati lexeotx.com (LXEO)|Balans kapitallashuviga qarzlar KRRO|Sof aktivlarga qarzlar editasmedicine.com EDIT|SLN: Balans kapitallashuviga qarzlar|PRQR: Qarzning balans qiymatiga nisbati|codexis.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Sangamo BioSciences|NAUT - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati metagenomi.co|DTIL (Precision BioSciences, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Exicure Inc. XCUR|IMNN: Balans kapitallashuviga qarzlar|Phio Pharmaceuticals (PHIO) - Qarzning balans qiymatiga nisbati|mustangbio.com - Qarzning balans qiymatiga nisbati|TransCode Therapeutics, Inc. (RNAZ) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar Bionano Genomics Inc.|Qarzning balans kapitallashuviga nisbati Applied DNA Corp|bluebird bio, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar immunoprecise.com (IPA)|Balans kapitallashuviga qarzlar OMGA (Omega Therapeutics, Inc.)|Singular Genomics Systems, Inc. - Balans kapitallashuviga qarzlar|RGLS: Qarzning balans kapitallashuviga nisbati|SYRS - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Telesis Bio, Inc.|TCON (traconpharma.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc. (UBX)